Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-21
2011-12-13
Jarrell, Noble (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S275000, C544S328000, C544S331000
Reexamination Certificate
active
08076343
ABSTRACT:
The present invention relates to compounds useful as inhibitors of Aurora, FLT-3, or PDK1 protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the invention.
REFERENCES:
patent: WO 2004056786 (2004-07-01), None
patent: WO 2005066156 (2005-07-01), None
Dorwald, F.Z. Side Reactions in Organic Synthesis, 2005, p. IX of preface.
Lyman et al. Blood, 1998, 91, 1101-34.
Binch Hayley
Everitt Simon
Mortimore Michael
Robinson Daniel
Stamos Dean
Chung H. Joon
Jarrell Noble
Vertex Pharmaceuticals Incorporated
LandOfFree
Benzimidazoles useful as inhibitors of protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazoles useful as inhibitors of protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazoles useful as inhibitors of protein kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4263274